ID: h-351aa1a927
Hypothesis

Astrocyte-specific autophagy deficiency induces NADPH oxidase-mediated oxidative stress in motor neurons via mitophagy impairment

We hypothesize that autophagy dysfunction specifically in astrocytes induces motor neuron toxicity through impaired mitophagy, leading to accumulation of damaged mitochondria that release mitochondrial DAMPs and trigger NADPH oxidase (NO.
🧬 ATG7🩺 als🎯 Composite 39%💱 $0.49▲1.6%proposed
neurodegeneration
EvidencePending (0%)📖 5 cit🗣 1 debates 5 support 1 oppose
✓ All Quality Gates Passed

🧪 Overview

We hypothesize that autophagy dysfunction specifically in astrocytes induces motor neuron toxicity through impaired mitophagy, leading to accumulation of damaged mitochondria that release mitochondrial DAMPs and trigger NADPH oxidase (NOX2) activation in adjacent motor neurons. The resulting oxidative stress drives motor neuron death through protein oxidation, lipid peroxidation, and mitochondrial dysfunction. This non-cell autonomous mechanism can be tested by: (1) generating GFAP-Cre;ATG7flox/flox mice to model astrocyte-specific autophagy deficiency, (2) co-culturing mutant astrocytes with hiPSC-derived motor neurons to quantify oxidative stress markers (4-HNE, 8-OHdG) and cell death, and (3) blocking NOX2 activity with gp91dstat to determine if motor neuron toxicity is rescued. This pathway would explain how glial autophagy defects accelerate ALS progression independent of neuronal autophagy status.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Astrocyte<br/>Autophagy Deficiency"]
    B["Mitophagy<br/>Impairment"]
    C["NADPH Oxidase<br/>ROS Overproduction"]
    D["Motor Neuron<br/>Oxidative Stress"]
    E["Astrocyte-Neuron<br/>Crosstalk Breakdown"]
    F["ATG7 Restoration<br/>as Therapeutic Target"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style F fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7

⚖️ Evidence

⚖️ Evidence Matrix5 supports0 contradicts
Supports
Endothelial depletion of Atg7 triggers astrocyte-microvascular disassociation at blood-brain barrier.
J Cell Biol2023PMID:36995368medium
Supports
Hepatic Encephalopathy and Astrocyte Senescence.
J Clin Exp Hepatol2018PMID:30302047medium
Supports
Nicotine influence on cerebrovascular and neurocognitive function with in utero electronic cigarette exposure.
J Physiol2025PMID:41064899medium
Supports
NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer's diseases.
Redox Biol2021PMID:33774476medium
Supports
Attenuating vascular stenosis-induced astrogliosis preserves white matter integrity and cognitive function.
J Neuroinflammation2021PMID:34454529medium
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — ATG7

No curated PDB or AlphaFold mapping for ATG7 yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for ATG7 from GTEx v10.

Frontal Cortex BA98.7 Cortex8.4 Cerebellum6.6 Cerebellar Hemisphere6.5 Anterior cingulate cortex BA245.9 Spinal cord cervical c-14.9 Nucleus accumbens basal ganglia4.4 Hypothalamus4.3 Substantia nigra4.2 Caudate basal ganglia4.1 Amygdala4.1 Hippocampus3.7 Putamen basal ganglia3.5median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for ATG7 →

No DepMap CRISPR Chronos data found for ATG7.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.7%
Volatility
High
0.0798
Events (7d)
2
Price History
▲1.6%

💾 Resource Usage

LLM Tokens
15,018
$0.0901
Total Cost
$0.0901

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF we treat astrocyte-motor neuron co-cultures (GFAP-Cre;ATG7flox/flox astrocytes + hiPSC-derived motor neurons) with the NOX2 inhibitor gp91dstat (10 μM), THEN motor neuron survival will increase by Motor neuron viability ≥60% (relative to baseline) and MitoSOX fluorescence intensity reduced to ≤50% of vehicle control levels in gp91dstat-treated co-cultures— no observation —pending0.72
IF we delete ATG7 specifically in astrocytes using GFAP-Cre;ATG7flox/flox mice, THEN lumbar motor neurons will show significantly elevated oxidative stress markers (4-HNE protein adducts and 8-OHdG DNAt least 2-fold increase in 4-HNE immunoreactivity and 1.5-fold increase in 8-OHdG-positive motor neurons in GFAP-Cre;ATG7flox/flox mice relative to controls— no observation —pending0.75
🔮 Falsifiable Predictions (2)
pendingconf 75%
IF we delete ATG7 specifically in astrocytes using GFAP-Cre;ATG7flox/flox mice, THEN lumbar motor neurons will show significantly elevated oxidative stress markers (4-HNE protein adducts and 8-OHdG DNA lesions) by 3-6 months of age compared to ATG7flox/flox littermate controls.
Predicted outcome: At least 2-fold increase in 4-HNE immunoreactivity and 1.5-fold increase in 8-OHdG-positive motor neurons in GFAP-Cre;ATG7flox/flox mice relative to c
Falsification: No significant difference in 4-HNE or 8-OHdG levels between GFAP-Cre;ATG7flox/flox mice and controls, indicating oxidative stress does not result from astrocyte autophagy deficiency
pendingconf 72%
IF we treat astrocyte-motor neuron co-cultures (GFAP-Cre;ATG7flox/flox astrocytes + hiPSC-derived motor neurons) with the NOX2 inhibitor gp91dstat (10 μM), THEN motor neuron survival will increase by at least 40% and mitochondrial ROS (MitoSOX) will decrease by at least 50% compared to vehicle-treat
Predicted outcome: Motor neuron viability ≥60% (relative to baseline) and MitoSOX fluorescence intensity reduced to ≤50% of vehicle control levels in gp91dstat-treated c
Falsification: No significant rescue of motor neuron survival or reduction in mitochondrial ROS despite NOX2 inhibition, indicating motor neuron toxicity is independent of NOX2 activation
Metadatasource: v1_phase_c_backfill · origin_type: audit_hypothesis_generator
sourcev1_phase_c_backfill
origin_typeaudit_hypothesis_generator
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.